In addition, S-588410 administration in a pre-surgical study on esophageal cancer has also shown to induce functional CD8 + and CD4 + TILs, specifically CD8 + PD-1 + and CD4 + PD-1 + cells [16]. The gene discussed is CD8A; the disease is esophageal cancer.